Jinyu Bio-technology Co., Ltd. (SHA:600201)

China flag China · Delayed Price · Currency is CNY
8.62
+0.07 (0.82%)
Jul 25, 2025, 11:29 AM CST
0.82%
Market Cap9.55B
Revenue (ttm)1.26B
Net Income (ttm)79.88M
Shares Out1.12B
EPS (ttm)0.07
PE Ratio117.64
Forward PE46.32
Dividend0.03 (0.35%)
Ex-Dividend DateJun 26, 2025
Volume36,988,268
Average Volume52,077,449
Open8.40
Previous Close8.55
Day's Range8.31 - 8.71
52-Week Range5.62 - 9.55
Beta0.69
RSI59.52
Earnings DateAug 30, 2025

About Jinyu Bio-technology

Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and i... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 1,740
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600201
Full Company Profile

Financial Performance

In 2024, Jinyu Bio-technology's revenue was 1.26 billion, a decrease of -21.45% compared to the previous year's 1.60 billion. Earnings were 108.99 million, a decrease of -61.57%.

Financial Statements

News

There is no news available yet.